At a glance
- Originator Shionogi
- Class
- Mechanism of Action Chymase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 28 Mar 2001 Preclinical development for Inflammation in Japan (Unknown route)